Moderna (MRNA) is trading at $219.50, below its 7-day and 20-day moving averages, while Piper Sandler raised its price target to $305 after the company’s sales beat and higher 2026 revenue outlook…. (Read More)Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here